The overall findings led the authors to reasonably postulate that the reduction in adrenal tumor chemerin concentrations could be an immune avoidance mechanism, but increased serum chemerin may counteract this in some individuals resulting in improved anti-tumor immune responses. Here, RARRES2 is linked to neoplasm.